Investigators from the departments of Neurology, Neurosurgery, Psychiatry, Medicine, and Biomedical Sciences at Cedars-Sinai have shown that an immune-suppressing drug similar to one used to treat severe COVID-19 reversed symptoms of delirium in mice whose lungs were injured during mechanical breathing assistance.
Cedars-Sinai researchers find that the immune system’s response to urinary tract infection causes brain changes and delirium in mice, paving the way for treatment in humans<br /><br />